BackEuropean Biotech Acquisition Overview

European Biotech Acquisition Selling, General & Admin

European Biotech Acquisition selling, general & admin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$1.13M
220.27% YoY

As of Dec 31, 2022

Annual SG&A Expenses (TTM)

$2.79M
205.34% YoY

Trailing 12 months ending Dec 31, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

European Biotech Acquisition (EBAC) FAQ

Stockcircle tracks selling, general & admin for European Biotech Acquisition (EBAC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for European Biotech Acquisition's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main EBAC overview so you can move from this figure to the surrounding analysis quickly.